Effect of Fish Oil as an Ethyl Ester or Triglyceride Preparation on Plasma Triglycerides in Hypertriglyceridemic Adults

The purpose of this small, short pilot study is to determine the feasibility (e.g., recruitment, dose acceptance, retention) of a future longer trial comparing the effects of two types of omega-3 fats from fish oil on plasma triglycerides. The two types of fish oil are composed of (1) omega-3 fatty acids in triglyceride form; and (2) as esterified free fatty acids (i.e. ethyl esters. Although these two types of fish oil supplements are available to the public, it remains unclear whether they are equally effective in lowering plasma triglycerides.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Investigator(s):

Intervention(s):

  • behavioral : Dietary Supplement: Fish Oil

Phase: Phase 2

Eligibility

Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

*Gender: Both women and men - Age: > or = 18 years - Ethnicity and race: All ethnic and racial backgrounds welcome - Fasting blood triglycerides greater than or equal to 150 mg/dL - Planning to be available for clinic visits for the 12 weeks of study participation - Ability and willingness to give written informed consent - No known active psychiatric illness.

External Links

Contact information

Primary Contact:

Antonella Dewell 6507368577

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: